Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2025 16:03 ET | Source: TELA Bio, Inc.

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

MALVERN, Pa., July 23, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
July 21, 2025 16:03 ET | Source: TELA Bio, Inc.

TELA Bio to Announce Second Quarter 2025 Financial Results

MALVERN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
June 06, 2025 16:05 ET | Source: TELA Bio, Inc.

TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., June 06, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
June 03, 2025 16:05 ET | Source: TELA Bio, Inc.

TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair

MALVERN, Pa., June 03, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
June 02, 2025 08:30 ET | Source: TELA Bio, Inc.

TELA Bio Appoints Jeffrey Blizard as President

MALVERN, Pa., June 02, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...
May 22, 2025 16:05 ET | Source: TELA Bio, Inc.

TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference

MALVERN, Pa., May 22, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions,...
May 09, 2025 16:05 ET | Source: TELA Bio, Inc.

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
May 08, 2025 16:05 ET | Source: TELA Bio, Inc.

TELA Bio Reports First Quarter 2025 Financial Results

MALVERN, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today...
April 17, 2025 16:05 ET | Source: TELA Bio, Inc.

TELA Bio to Announce First Quarter 2025 Financial Results

MALVERN, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
March 31, 2025 07:00 ET | Source: TELA Bio, Inc.

TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery

MALVERN, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on advancing soft-tissue reconstruction solutions, today...